An Oncogene-Induced DNA Damage Model for Cancer Development

  • Thanos D. Halazonetis
    Department of Molecular Biology and Department of Biochemistry, University of Geneva, CH-1205 Geneva, Switzerland.
  • Vassilis G. Gorgoulis
    Department of Molecular Biology and Department of Biochemistry, University of Geneva, CH-1205 Geneva, Switzerland.
  • Jiri Bartek
    Department of Molecular Biology and Department of Biochemistry, University of Geneva, CH-1205 Geneva, Switzerland.

書誌事項

公開日
2008-03-07
DOI
  • 10.1126/science.1140735
公開者
American Association for the Advancement of Science (AAAS)

この論文をさがす

説明

<jats:p> Of all types of DNA damage, DNA double-strand breaks (DSBs) pose the greatest challenge to cells. One might have, therefore, anticipated that a sizable number of DNA DSBs would be incompatible with cell proliferation. Yet recent experimental findings suggest that, in both precancerous lesions and cancers, activated oncogenes induce stalling and collapse of DNA replication forks, which in turn leads to formation of DNA DSBs. This continuous formation of DNA DSBs may contribute to the genomic instability that characterizes the vast majority of human cancers. In addition, in precancerous lesions, these DNA DSBs activate <jats:italic>p53</jats:italic> , which, by inducing apoptosis or senescence, raises a barrier to tumor progression. Breach of this barrier by various mechanisms, most notably by <jats:italic>p53</jats:italic> mutations, that impair the DNA damage response pathway allows cancers to develop. Thus, oncogene-induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of <jats:italic>p53</jats:italic> mutations. </jats:p>

収録刊行物

  • Science

    Science 319 (5868), 1352-1355, 2008-03-07

    American Association for the Advancement of Science (AAAS)

被引用文献 (55)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ